Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-41P is a pseudogene originating from the U6 small nuclear RNA gene family. U6 snRNA itself is an essential non-coding RNA that forms part of the spliceosome—a molecular machine responsible for removing introns from pre-mRNA in the nucleus. Numerous copies and pseudogenes of U6 snRNA exist in the human genome, reflecting the functional RNA's evolutionary importance[5][1]. Unlike its parent gene, RNU6-41P typically does not encode a functional RNA and lacks direct biological function. Pseudogenes such as RNU6-41P are not known to be therapeutic targets and are not involved in canonical receptor, enzyme, transporter, or signaling pathways[1][5].\n\nIf you are seeking a functional target, the correct entity would be U6 small nuclear RNA (U6 snRNA), but not pseudogenes thereof[1][5].
None\nDrugs do not act on this molecule.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on U6 small nuclear RNA 41, pseudogene (RNU6-41P).